Growth hormone involved in diabetic kidney disease, study finds

SAN DIEGO -- A new study of growth hormone suggests it plays a role in the onset of Type I diabetes-induced kidney disease. Called diabetic nephropathy, the disease affects 10 percent to 21 percent of all people with diabetes.

Researchers at Ohio University induced Type I diabetes in normal mice and in mice in which the growth hormone receptor that binds the substance to cells had been genetically disrupted.

Ten weeks later, they examined the kidneys of all the mice. While the normal mice had evidence of diabetic kidney disease, the mice whose receptors had been disrupted did not.

"This clearly suggests growth hormone is important in the development of Type I diabetes-induced kidney damage," said John Kopchick, Goll-Ohio Eminent Scholar and professor of molecular biology at Ohio University.

The findings were presented June 13 at the annual meeting of the Endocrine Society in San Diego.

Produced by the pituitary gland, growth hormone promotes normal body growth and development by altering chemical activity in cells. It stimulates the production of protein in muscle cells and the release of energy from the breakdown of fats.

Kopchick led the team of researchers working on this project, which is part of a larger study under way in the university's Edison Biotechnology Institute that has resulted in the development of growth hormone antagonists, the basis for a new class of drugs that one day may be used to treat a variety of diseases, including acromegaly, some forms of cancer and diabetic eye disease.

Growth hormone antagonists inhibit the action of the hormone at the cellular level by binding to receptors usually claimed by growth hormone.

Human and animal growth hormones contain a chain of 191 amino acids. Kopchick's research team, which included co-inventor Wen Chen, a former senior scientist with the institute now with Clemson University, discovered that

Contact: Kelli Whitlock
Ohio University

Page: 1 2 3

Related biology news :

1. Growth hormone and IBD: Reduction of intestinal inflammation, promotion of growth
2. Growth study of wild chimpanzees challenges assumptions about early humans
3. Growth hormone activates gene involved in healing damaged tissue
4. Growth factor shows promise in Parkinsons patients
5. Growth hormone could make farm fish bigger, faster to market
6. Growth hormone may stimulate production of T cells to boost bodys ability to fight HIV
7. Growth hormone may boost production of disease-fighting cells in elderly
8. Growth factor receptor signaling critical to intestinal tumor development, studies show
9. Growth factor may determine who grows new blood vessels that protect against heart attacks
10. Report: High Carbon Dioxide Boosts Duke Forest Growth By 25 Percent
11. UC Berkeley Conference On Population Growth And The Environment

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: